Retatrutide is still experimental. It hasn’t been approved for use anywhere in the world, yet it’s already circulating through illicit online markets. Retatrutide, often shortened to “reta”, is a ...

Eli Lilly is just wrapping up trials of its retatrutide, but consumers already are flocking to black-market versions. Can Lilly compete with copies of its own drug?

The latest clinical trial results for retatrutide suggest this experimental drug could help adults with obesity shed more ...

The weight loss drug conversation has been accelerating for years – from the early Ozempic headlines through the Wegovy wave ...

Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

Retatrutide altered circulating metabolites and lipids linked to fatty acid oxidation and insulin resistance in people with ...

A once-weekly triple receptor agonist conferred up to 28.3% weight loss at 80 weeks for adults with overweight or obesity, ...

Retatrutide demonstrated substantial dose-dependent improvements in waist circumference and crucial cardiovascular risk factors, including non-HDL-C, triglycerides, systolic blood pressure, and ...

The once‑weekly “triple hormone” injection outperformed blockbuster drugs like Wegovy and Zepbound but caused more ...

Julian Becerra first learned about retatrutide while scrolling social media. The 24-year-old saw Dawson Weiss, a bodybuilder, post unbelievable photos on TikTok — his muscles rippling, his torso ...

Retatrutide, Eli Lilly’s next obesity shot, showed far more weight loss in clinical trial patients than other blockbuster ...